Atlas Trials

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Clinical trial NCT05015972 · WITHDRAWN

Trial details

NCT number
NCT05015972
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
B-cell Lymphoma
Start date
2021-08-20
Primary completion
2023-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.